Press Releases

  DECEMBER 29, 2010
07:00 AM CELCEL-SCI Commences Phase III Clinical Trial in Head and Neck Cancer

  DECEMBER 15, 2010
10:50 AM CEL-SCI Corporation Receives Government Approval from Ukraine to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

  DECEMBER 13, 2010
08:30 AM CEL-SCI Corporation Announces Fiscal 2010 Financial Results

  DECEMBER 8, 2010
09:40 AM CEL-SCI Corporation's Manufacturing and Laboratory Operations Deemed Compliant with GMP Requirements Following Audit by European Union Qualified Person

  DECEMBER 2, 2010
09:40 AM CEL-SCI Corporation Receives Government Approval from Taiwan to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

  NOVEMBER 22, 2010
09:45 AM CEL-SCI Completes Global Investigator Meeting in Preparation for Enrollment and Treatment of Patients in Phase III Head and Neck Cancer Trial

  NOVEMBER 1, 2010
12:22 PM CEL-SCI Corporation Receives $733,437 Grant under the Patient Protection and Affordable Care Program

  OCTOBER 20, 2010
09:15 AM CEL-SCI Corporation Receives Approval from Seven Hospital Institutional Review Boards in India to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

  OCTOBER 12, 2010
09:35 AM CEL-SCI Corporation Receives Approval from First Taiwanese Institutional Review Board to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

  OCTOBER 5, 2010
09:00 AM CEL-SCI Corporation Receives Approval from Hungary to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

  SEPTEMBER 27, 2010
09:00 AM CEL-SCI Corporation Receives Russian Federation Ethical Council Approval for Multikine Phase III Clinical Trial in Head and Neck Cancer

  SEPTEMBER 13, 2010
09:45 AM CEL-SCI Corporation Receives Approval from North Mississippi Health Services' Institutional Review Board to Commence Phase III Clinical Trial of Multikine in Head and Neck Cancer

  AUGUST 16, 2010
04:11 PM CEL-SCI Corporation Reports Third Quarter 2010 Financial Results

  AUGUST 4, 2010
09:45 AM CEL-SCI Successfully Produces and Fills Multikine in New Manufacturing Facility

  JUNE 28, 2010
09:00 AM CEL-SCI Collaborator Presents Data Showing LEAPS Vaccine Technology Generates Dendritic Cells that can Protect Animals Against Viral Illness and Other Diseases

  MAY 27, 2010
9:15 AM CEL-SCI Announces Presentation by its Chief Scientific Officer at "Targeted Cancer Therapies" Conference in London Today

  MAY 17, 2010
4:18 PM CEL-SCI Corporation Reports Second Quarter 2010 Financial Results

  MAY 12, 2010
12:27 PM CEL-SCI to Present at the 6th Annual Rodman and Renshaw Global Healthcare Conference

  MAY 5, 2010
09:42 AM CEL-SCI Provides Update on Pivotal Phase III Study of Cancer Immunotherapy Drug Multikine

  MARCH 10, 2010
10:30 AM CEL-SCI Receives Payment from Marketing Partner

  FEBRUARY 22, 2010
09:45 AM CEL-SCI Study Shows CEL-2000 Vaccine Blocks Progression Of Rheumatoid Arthritis

  FEBRUARY 17, 2010
09:00 AM CEL-SCI Corporation Releases Letter To Shareholders

  FEBRUARY 16, 2010
09:00 AM CEL-SCI Corporation Reports First Quarter 2010 Financial Results

  FEBRUARY 3, 2010
09:00 AM CEL-SCI To Present At 12TH Annual BIO CEO & Investor Conference

  JANUARY 15, 2010
09:35 AM CEL-SCI Hires Vice President Of Manufacturing/Facilities And Commercial Operations

  JANUARY 13, 2010
04:20 PM CEL-SCI Corporation Announces 2009 Financial Results

  JANUARY 11, 2010
09:30 AM CEL-SCI Completes Validation Of Manufacturing Facility Allowing It To Commence Manufacturing Of Multikine

 

   Go to:

            Press Releases - 2008

            Press Releases - 2009

            Press Releases - Current

 

 

News & Announcements

 

  

Webcasts